The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: The possible role of leukotrienes in exercise-induced refractoriness

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1155-1161

  Dessanges, Jean François ^a,b   Préfaut, Christian ^c   Taytard, André ^d   Matran, Régis ^f   Naya, Ian ^f   Compagnon, Anne ^e   Dinh Xuan, A Tuan ^a,b  

^a AP HP Université Paris 5 ^*  (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e Zeneca Pharma   (France)

^f Hôpital Cochin ^*

Author keywords

Exercise induced asthma; Exercise induced refractoriness; Leukotriene receptor antagonists; Zafirlukast

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; SALBUTAMOL; TERBUTALINE; ZAFIRLUKAST;

ADULT; ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033459579     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70007-2     Document Type: Article

References (26)

1. 1. O'Byrne PM. Leukotrienes in bronchoconstriction induced by exercise and other indirect triggers. In: Holgate S, Dahlén S-E, editors, SRS-A to leukotrienes, 1st ed. London: Blackwell Science: 1997. p. 255-66.
2. 2. McFadden ER, Lenner KAM, Strohl KP. Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. J Clin Invest 1986;78:18-25.
3. 4-agonist, methoxamine, reduces exercise-induced asthma. Eur Respir J 1989;2:409-14.
4. 4. Lockhart A, Dinh-Xuan AT, Regnard J, Cabanes L, Matran R. Effect of airway blood on airflow. Am Rev Respir Dis 1992;146:519-23.
5. 5. Anderson SD, Daviskas E, Smith CM. Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Asthma Proc 1989;10:215-26.
6. 6. Anderson SD, Schoeffel RE, Black JL, Daviskas E. Airway cooling as the stimulus to exercise-induced asthma - a re-evalualion. Eur J Respir Dis 1985;67:20-30.
7. 7. Bjornsdottir US, Budsh RK. Leukotriene antagonists and inhibitors. Immunol Allergy Clin North Am 1993;13:861-90.
8. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:1030-5.
9. 4 receptor antagonist. Am Rev Respir Dis 1992;145:746-9.
10. 4 receptor antagonist. N Engl J Med 1990;323:1736-9.
11. 11. Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi M, et al. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). Am Rev Respir Dis 1992;146:1285-8.
12. 12. Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther 1997;62:556-61.
13. 13. Meltzer SS, Hasday JF, Cohn J, Bleeker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996;153:931-5.
14. 14. Chan-Yeung MMW, Vyas MN, Grzybowski S. Exercise-induced asthma. Am Rev Respir Dis 1971;104.915-23.
15. 15. James L, Faciane J, Sly RM. Effect of treadmill exercise on asthmatic children. J Allergy Clin Immunol 1976;57:408-16.
16. 16. Edmunds AT, Tooley M, Godfrey S. The refractory period after exercise-induced asthma: its duration and relation to severity of exercise. Am Rev Respir Dis 1978;117:247-54.
17. 17. Krell RD, Aharony D, Buckner CK, Keith RA, Kusner EJ, Snyder DW, et al. The pre-clinical pharmacology of ICI 204,219. Am Rev Respir Dis 1990;141:978-87.
18. 4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am Rev Respir Dis 1993;147:1413-8.
19. 19. Pearlman DS, Ostrom NK, Bronsky EA, Bonucelli CM, Hanby LA. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children. J Pediatr 1999;134:273-9.
20. 20. Adkins JC, Brogen RN. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. Drugs 1998;55:121-44.
21. 21. Kemp JP, Dockhom RJ, Busse WW, Bleecker ER, Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med 1994;150:1612-5.
22. 22. Manning PJ, Watson RM, O'Byme PM. Exercise-induced refractoriness in asthmatic subjects involve leukotriene and prostaglandin interdependent mechanisms. Am Rev Respir Dis 1993;148:950-4.
23. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994;149:1138-41.
24. 24. Inman M O'Byme PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am Rev Respir Crit Care Med 1996;153:65-9.
25. 25. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise-induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1995;88:363-8.
26. 26. Left JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced, bronchoconstriction. N Engl J Med 1998;339:147-52.